{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP01378",
    "Peptide Name": "DEFA1 (defensin alpha 1, natural AMPs; horse defensin, UCSS1a; mammals, animals; horsy; 3S=S)",
    "Source": "Paneth cells;Equus caballus",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "SCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR",
    "Sequence Length": 34,
    "UniProt Entry": "",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "candidacidal"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Beta",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "2MXQ",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 7,
    "Boman Index": 3.67,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "35%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Similar to human HD5. DEFA1 showed an antimicrobial activity against different Gram-positive and Gram-negative bacteria (E. coli ATCC 11775; E. coli ATCC 25922; E. coli ATCC 35218;  E. coli D31, K. pneumoniae ATCC 13883, E. cloacae ATCC 13047; P. aeruginosa ATCC 10145; P. aeruginosa ATCC 11440; B. cepacia ATCC 25416; S. aureus ATCC 6538; S. aureus ATCC 12600; S. epidermidis ATCC 14990; E. faecalis ATCC 29212; E. faecalis PEG 205; S. pyogenes ATCC 12344; B. megaterium ATCC 14581) and against the yeast C. albicans ATCC 24433.O. Bruhn et al.showed this peptide is also active against horse pathogens such as R. equi ATCC 33701 P\u0002  ,R. equi ATCC 33701 P+, R. equi 85 FP+ S. equi subsp. zooepidemicus ,S. equi subsp. equi, S. dysgalactiae subsp. equisimilis    , S. choleraesuis  .  Membrane permeabilization is at least an essential part of the peptide's mode of action. 3D structure of the peptide has been determned by  2D NMR spectroscopy (Michalek M et al., 2015). Residues 3-6, 15-17, and 30-32 are the three beta stranded regions.You can rotate, zoom, and view the 3D structureherein the PDB. Updated 3/2015; seq & PDB link 11/2015.",
    "Author": "Bruhn O, Regenhard P, Michalek M, Paul S, Gelhaus C, Jung S, Thaller G, Podschun R, Leippe M, Gr√∂tzinger J, Kalm E.2007",
    "Reference": "Biochem J. 2007 Oct 15;407(2):267-76.PubMed.",
    "Title": "A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function."
  },
  "3D Structure": []
}